购物车
- 全部删除
- 您的购物车当前为空
TAM-16是一种有效的口服活性聚酮合酶13 (Pks13) 抑制剂,IC50值为0.32 μM,对Mycobacterium tuberculosis具有抗结核分枝杆菌活性,并抑制hERG心脏离子通道。
TAM-16是一种有效的口服活性聚酮合酶13 (Pks13) 抑制剂,IC50值为0.32 μM,对Mycobacterium tuberculosis具有抗结核分枝杆菌活性,并抑制hERG心脏离子通道。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | TAM-16 is a potent, orally active inhibitor of polyketide synthase 13 (Pks13) with an IC50 value of 0.32 μM, demonstrating promising activity against Mycobacterium tuberculosis. Additionally, TAM-16 inhibits the hERG cardiac ion channel [1] [2]. |
体外活性 | TAM-16 (compound 1) inhibits M. tuberculosis strain H37Rv with an IC50 value of 0.08 μM [1] and targets Pks13 to inhibit Mycobacterium tuberculosis at concentrations of 0-10 μM [1]. |
体内活性 | 在一项关于BALB/c小鼠结核病(TB)模型的研究中,TAM-16 (compound 1) 的口服处理剂量为200 mg/kg,每日一次,连续服用14天,显著减少了肺部的CFU(colony-forming units)计数,与未经治疗的对照小鼠相比,减少了约0.9 log 10 [2]。这表明TAM-16能有效预防小鼠TB感染模型中的典型肺部病变。 |
分子量 | 380.44 |
分子式 | C22H24N2O4 |
CAS No. | 2030241-59-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容